Ludwig Dubois
Ludwig Dubois
Adresse e-mail validée de maastrichtuniversity.nl
Titre
Citée par
Citée par
Année
The unfolded protein response protects human tumor cells during hypoxia through regulation of the autophagy genes MAP1LC3B and ATG5
KMA Rouschop, T Van Den Beucken, L Dubois, H Niessen, J Bussink, ...
The Journal of clinical investigation 120 (1), 127-141, 2010
6602010
Disparity between in vivo EGFR expression and 89Zr-labeled cetuximab uptake assessed with PET
HJWL Aerts, L Dubois, L Perk, P Vermaelen, GAMS van Dongen, ...
Journal of Nuclear Medicine 50 (1), 123-131, 2009
2082009
Imaging of CA IX with fluorescent labelled sulfonamides distinguishes hypoxic and (re)-oxygenated cells in a xenograft tumour model
L Dubois, NG Lieuwes, A Maresca, A Thiry, CT Supuran, A Scozzafava, ...
Radiotherapy and Oncology 92 (3), 423-428, 2009
1822009
Taking advantage of tumor cell adaptations to hypoxia for developing new tumor markers and treatment strategies
P Ebbesen, EO Pettersen, TA Gorr, G Jobst, K Williams, J Kieninger, ...
Journal of enzyme inhibition and medicinal chemistry 24 (sup1), 1-39, 2009
1742009
Specific inhibition of carbonic anhydrase IX activity enhances the in vivo therapeutic effect of tumor irradiation
L Dubois, S Peeters, NG Lieuwes, N Geusens, A Thiry, S Wigfield, F Carta, ...
Radiotherapy and Oncology 99 (3), 424-431, 2011
1702011
Imaging the hypoxia surrogate marker CA IX requires expression and catalytic activity for binding fluorescent sulfonamide inhibitors
L Dubois, K Douma, CT Supuran, RK Chiu, MAMJ van Zandvoort, ...
Radiotherapy and oncology 83 (3), 367-373, 2007
1542007
How do changes in the mtDNA and mitochondrial dysfunction influence cancer and cancer therapy? Challenges, opportunities and models
MW van Gisbergen, AM Voets, MHW Starmans, IFM de Coo, R Yadak, ...
Mutation Research/Reviews in Mutation Research 764, 16-30, 2015
1402015
PERK/eIF2α signaling protects therapy resistant hypoxic cells through induction of glutathione synthesis and protection against ROS
KM Rouschop, LJ Dubois, TG Keulers, T van den Beucken, P Lambin, ...
Proceedings of the National Academy of Sciences 110 (12), 4622-4627, 2013
1372013
Repeated cycles of Clostridium-directed enzyme prodrug therapy result in sustained antitumour effects in vivo
J Theys, O Pennington, L Dubois, G Anlezark, T Vaughan, A Mengesha, ...
British journal of cancer 95 (9), 1212-1219, 2006
1322006
A comparative study of the hypoxia PET tracers [18F] HX4,[18F] FAZA, and [18F] FMISO in a preclinical tumor model
SGJA Peeters, CML Zegers, NG Lieuwes, W van Elmpt, J Eriksson, ...
International Journal of Radiation Oncology* Biology* Physics 91 (2), 351-359, 2015
1282015
Evaluation of hypoxia in an experimental rat tumour model by [18 F] fluoromisonidazole PET and immunohistochemistry
L Dubois, W Landuyt, K Haustermans, P Dupont, G Bormans, ...
British Journal of Cancer 91 (11), 1947-1954, 2004
1232004
Preclinical evaluation and validation of [18F] HX4, a promising hypoxia marker for PET imaging
LJ Dubois, NG Lieuwes, MHM Janssen, WJM Peeters, AD Windhorst, ...
Proceedings of the National Academy of Sciences 108 (35), 14620-14625, 2011
1212011
PET imaging of hypoxia using [18F]HX4: a phase I trial
J van Loon, MHM Janssen, M Öllers, HJWL Aerts, L Dubois, ...
European journal of nuclear medicine and molecular imaging 37 (9), 1663-1668, 2010
1132010
Synthesis and biological evaluation of a 99mTc-labelled sulfonamide conjugate for in vivo visualization of carbonic anhydrase IX expression in tumor hypoxia
V Akurathi, L Dubois, NG Lieuwes, SK Chitneni, BJ Cleynhens, D Vullo, ...
Nuclear medicine and biology 37 (5), 557-564, 2010
952010
Decision support systems for personalized and participative radiation oncology
P Lambin, J Zindler, BGL Vanneste, L Van De Voorde, D Eekers, ...
Advanced drug delivery reviews 109, 131-153, 2017
872017
Is there a causal relationship between genetic changes and radiomics-based image features? An in vivo preclinical experiment with doxycycline inducible GADD34 tumor cells
KM Panth, RTH Leijenaar, S Carvalho, NG Lieuwes, A Yaromina, ...
Radiotherapy and Oncology 116 (3), 462-466, 2015
862015
Targeting tumour hypoxia to prevent cancer metastasis. From biology, biosensing and technology to drug development: the METOXIA consortium
EO Pettersen, P Ebbesen, RG Gieling, KJ Williams, L Dubois, P Lambin, ...
Journal of enzyme inhibition and medicinal chemistry 30 (5), 689-721, 2015
842015
TH-302 in combination with radiotherapy enhances the therapeutic outcome and is associated with pretreatment [18F] HX4 hypoxia PET imaging
SGJA Peeters, CML Zegers, R Biemans, NG Lieuwes, ...
Clinical Cancer Research 21 (13), 2984-2992, 2015
812015
Prognostic significance of carbonic anhydrase IX expression in cancer patients: a meta-analysis
SJA van Kuijk, A Yaromina, R Houben, R Niemans, P Lambin, LJ Dubois
Frontiers in oncology 6, 69, 2016
772016
Targeting carbonic anhydrase IX by nitroimidazole based sulfamides enhances the therapeutic effect of tumor irradiation: a new concept of dual targeting drugs
L Dubois, SGJA Peeters, SJA van Kuijk, A Yaromina, NG Lieuwes, ...
Radiotherapy and Oncology 108 (3), 523-528, 2013
712013
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20